Abstract:Gliomas, and in particular glioblastoma multiforme, are aggressive brain tumors characterized by a poor prognosis and high rates of recurrence. Current treatment strategies are based on open surgery, chemotherapy (temozolomide) and radiotherapy. However, none of these treatments, alone or in combination, are considered effective in managing this devastating disease, resulting in a median survival time of less than 15 months. The efficiency of chemotherapy is mainly compromised by the blood-brain barrier (BBB) that selectively inhibits drugs from infiltrating into the tumor mass. Cancer stem cells (CSCs), with their unique biology and their resistance to both radio- and chemotherapy, compound tumor aggressiveness and increase the chances of treatment failure. Therefore, more effective targeted therapeutic regimens are urgently required. In this article, some well-recognized biological features and biomarkers of this specific subgroup of tumor cells are profiled and new strategies and technologies in nanomedicine that explicitly target CSCs, after circumventing the BBB, are detailed. Major achievements in the development of nanotherapies, such as organic poly(propylene glycol) and poly(ethylene glycol) or inorganic (iron and gold) nanoparticles that can be conjugated to metal ions, liposomes, dendrimers and polymeric micelles, form the main scope of this summary. Moreover, novel biological strategies focused on manipulating gene expression (small interfering RNA and clustered regularly interspaced short palindromic repeats [CRISPR]/CRISPR associated protein 9 [Cas 9] technologies) for cancer therapy are also analyzed. The aim of this review is to analyze the gap between CSC biology and the development of targeted therapies. A better understanding of CSC properties could result in the development of precise nanotherapies to fulfill unmet clinical needs.

Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives

Mechanical Nanosurgery of Chemoresistant Glioblastoma Using Magnetically Controlled Carbon Nanotubes

Current Status and Future Perspectives of Sonodynamic Therapy in Glioma Treatment.

Nanoradiosensitizers in glioblastoma treatment: recent advances and future perspectives

Imaging-guided Focused Ultrasound-Induced Thermal and Sonodynamic Effects of Nanosonosensitizers for Synergistic Enhancement of Glioblastoma Therapy.

Targeted Delivery of Chemo-Sonodynamic Therapy via Brain Targeting, Glutathione-Consumable Polymeric Nanoparticles for Effective Brain Cancer Treatment

Advances in nanotechnology for the treatment of GBM

Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions

Nanotechnology-enabled sonodynamic therapy against malignant tumors

Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma

Metal-Doping Strategy for Carbon-Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma

Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma

Advances in blood–brain barrier-crossing nanomedicine for anti-glioma

Blood-Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges

Glioma targeted therapy: insight into future of molecular approaches

Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma

Targeted Nanotechnology in Glioblastoma Multiforme

Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology

Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives

Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment

Nanomedicines Targeting Glioma Stem Cells